EA200702171A1 - PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE - Google Patents

PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE

Info

Publication number
EA200702171A1
EA200702171A1 EA200702171A EA200702171A EA200702171A1 EA 200702171 A1 EA200702171 A1 EA 200702171A1 EA 200702171 A EA200702171 A EA 200702171A EA 200702171 A EA200702171 A EA 200702171A EA 200702171 A1 EA200702171 A1 EA 200702171A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
local application
application containing
containing nimesulide
nimesulide
Prior art date
Application number
EA200702171A
Other languages
Russian (ru)
Inventor
Итка Фортова
Зденька Мрвова
Павлина Кристенова
Original Assignee
ЗЕНТИВА, а.с.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЗЕНТИВА, а.с. filed Critical ЗЕНТИВА, а.с.
Publication of EA200702171A1 publication Critical patent/EA200702171A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

Фармацевтический состав для местного применения, содержащий нимесулид, содержит гидратирующий агент, предпочтительно пропиленгликоль, неионное поверхностно-активное вещество и возможно другие фармацевтически приемлемые добавки.A topical pharmaceutical composition containing nimesulide contains a hydrating agent, preferably propylene glycol, a non-ionic surfactant, and possibly other pharmaceutically acceptable additives.

EA200702171A 2005-04-06 2006-04-06 PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE EA200702171A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20050214A CZ297215B6 (en) 2005-04-06 2005-04-06 Topical medicamentous form containing nimesulide
PCT/CZ2006/000016 WO2006105741A2 (en) 2005-04-06 2006-04-06 Topical pharmaceutical formulation containing nimesulide

Publications (1)

Publication Number Publication Date
EA200702171A1 true EA200702171A1 (en) 2008-04-28

Family

ID=37073817

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702171A EA200702171A1 (en) 2005-04-06 2006-04-06 PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING NIMESULIDE

Country Status (4)

Country Link
EP (1) EP1879565A2 (en)
CZ (1) CZ297215B6 (en)
EA (1) EA200702171A1 (en)
WO (1) WO2006105741A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2519193C2 (en) 2008-09-12 2014-06-10 Критикал Фармасьютикалс Лимитед Improving absorption of therapeutic agents through mucous membranes or skin
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011002A1 (en) * 1994-10-05 1996-04-18 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory agent for external use
IN188720B (en) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
RU2188007C2 (en) * 1998-10-27 2002-08-27 Панацея Биотек Лимитед New antiallergic antiphlogistic composition and method for its obtaining
EP1734925A2 (en) * 2004-03-18 2006-12-27 Panacea Biotec Ltd. Novel compositions for topical delivery

Also Published As

Publication number Publication date
CZ2005214A3 (en) 2006-10-11
EP1879565A2 (en) 2008-01-23
WO2006105741B1 (en) 2007-04-19
CZ297215B6 (en) 2006-10-11
WO2006105741A2 (en) 2006-10-12
WO2006105741A3 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
ES2527242T3 (en) Compositions comprising a germinant and an antimicrobial agent
ATE447568T1 (en) NEW PYRINE DERIVATIVES
WO2007100776A3 (en) Antimicrobial compositions and methods for locking catheters
NO20030929D0 (en) Guanidinobenzamides as MC4-R agonists
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
RS52169B (en) Stable laquinimod preparations
BRPI0509184A (en) pharmaceutical compositions
DK1799633T3 (en) Crystal forms of (-) - (1R, 2R) -3- (3-dimethylamino-1-ethyl-2-methylpropyl) phenol hydrochloride for use as active ingredient in pharmaceutical compositions
CL2009000882A1 (en) A compound n- (4-chloro-3- (pyridin-2-yl) phenyl) -4- (2-hydroxy-2-methylpropylsulfonyl) -2-methylbenzamide, inhibitor of the hedgehog signaling pathway; pharmaceutical composition comprising said compound; and its use to treat cancer.
ECSP099072A (en) IMPROVED STABILITY PHENYLEFRINE LIQUID COMPOSITIONS
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
WO2006138735A3 (en) Gel compositions for topical administration
TW200708511A (en) Novel thiophene derivatives
ECSP077239A (en) PHARMACEUTICAL FORMULATION
GT200600520A (en) ANTIBACTERIAL AGENTS
DK1814848T3 (en) 2,3,4-substituted-cyclopentanones as therapeutic agents
SG165404A1 (en) Fulvestrant formulation
BRPI0611025A2 (en) compound, use of a compound, and pharmaceutically acceptable composition
GT200800107A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
ZA200709296B (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
BRPI0619911A2 (en) compound, prodrug, pharmaceutical agent, and compound use
PE20150773A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE
DK2234645T3 (en) PEG-interferon-beta formulations